Attenuation of Myocardial Dysfunction in Hypertensive Cardiomyopathy Using Non-R-Wave-Synchronized Cardiac Shock Wave...

Area of Science:

• Cardiology
• Regenerative Medicine

Background:

• Hypertensive cardiomyopathy leads to significant cardiac dysfunction.
• Conventional therapies are often insufficient for refractory cases.
• Cardiac shock wave therapy (CSWT) offers a novel approach.

Purpose of the Study:

• To investigate the mechanism and efficacy of non-R-wave-triggered CSWT.
• To assess CSWT's impact on hypertensive cardiomyopathy in a large animal model.
• To evaluate CSWT's effects on myocardial neovascularization and inflammation.

Main Methods:

• Induced sustained hypertension in pigs using angiotensin-II and DOCA.
• Administered two sessions of non-R-wave-triggered CSWT.
• Assessed cardiac function, blood pressure, and myocardial tissue characteristics.

Main Results:

• CSWT attenuated the decrease in cardiac function (+dP/dt, ESPVR) observed in the hypertension group.
• CSWT improved diastolic function (EDPVR) and increased microvascular density.
• CSWT upregulated vascular endothelial growth factor (VEGF) and reduced inflammation.

Conclusions:

• Non-R-wave-triggered CSWT is safe and effective in a large animal model of hypertensive cardiomyopathy.
• CSWT attenuates left ventricular systolic and diastolic dysfunction.
• The therapeutic effects are mediated by enhanced myocardial neovascularization and anti-inflammatory actions.